Breaking News Instant updates and real-time market news.

TCRR

TCR2 Therapeutics

$16.85 /

-0.07 (-0.41%)

06:51
08/12/20
08/12
06:51
08/12/20
06:51

TCR2 Therapeutics reports Q2 EPS (67c), consensus (64c)

TCR2 ended Q2 with $124.8M in cash, cash equivalents, and investments compared to $158.1M as of December31, 2019. As a result of the recent equity offering, TCR2 raised an additional $134.6M. TCR2 continues to project net cash use of $60M-$70M for 2020. "Q2 was incredibly strong for the company as we continued to deliver significant progress in our clinical trials of TC-210 and TC-110 despite the pandemic. We are particularly pleased to update that, following the earlier announcement of five of our first five cancer patients showing tumor regression with TC-210, one patient is now a confirmed partial response based on independent central review and experienced further tumor regression from 42% to 75%," said CEO Garry Menzel. "The initial data from TC-210 provide meaningful readthrough for our TRuC-T cell platform and we believe our robust preclinical pipeline supports our next phase of growth as we build a leading cell therapy company treating solid tumors. The strengthening of our balance sheet through our recent financing puts us in an excellent position to execute on our objectives and provide further clinical and scientific updates in 2020."

  • 12

    Aug

  • 29

    Jul

TCRR TCR2 Therapeutics
$16.85 /

-0.07 (-0.41%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
07/27/20 H.C. Wainwright
TCR2 Therapeutics price target raised to $33 from $19 at H.C. Wainwright
07/27/20 Roth Capital
TCR2 Therapeutics upgraded to Buy from Neutral at Roth Capital
07/27/20 Wedbush
TCR2 Therapeutics price target raised to $32 from $25 at Wedbush

TODAY'S FREE FLY STORIES

Earnings
Jushi Holdings raises FY21 revenue $205M-$255M from $200M-$250M » 08:00
10/01/20
10/01
08:00
10/01/20
08:00
JUSHF

Jushi Holdings

$0.00 /

+ (+0.00%)

Sees adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

General news
U.S. Challenger reported announced job cuts rose 3.0k to 118.8k in September » 08:00
10/01/20
10/01
08:00
10/01/20
08:00

U.S. Challenger reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Jushi Holdings sees Q4 revenue at high end of $25M-$20M guidance » 07:59
10/01/20
10/01
07:59
10/01/20
07:59
JUSHF

Jushi Holdings

$0.00 /

+ (+0.00%)

Expects to report…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

Earnings
Jushi Holdings sees narrows Q3 revenue view $24M from $22M-$25M  07:58
10/01/20
10/01
07:58
10/01/20
07:58
JUSHF

Jushi Holdings

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

Recommendations
Azure partnership underscores Datadog's leading position, says Morgan Stanley » 07:58
10/01/20
10/01
07:58
10/01/20
07:58
DDOG

Datadog

$102.55 /

+11.62 (+12.78%)

, MSFT

Microsoft

$210.30 /

+3.13 (+1.51%)

After Datadog (DDOG)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

06:41 Today Mizuho
Datadog price target raised to $116 from $100 at Mizuho
09/25/20 Baird
Baird starts Datadog at Neutral, citing 'premium valuation'
09/24/20 Baird
Datadog initiated with a Neutral at Baird
09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

06:41 Today Mizuho
Datadog price target raised to $116 from $100 at Mizuho
09/29/20 Summit Insights
Mimecast downgraded to Hold from Buy at Summit Insights
09/29/20 Morgan Stanley
RingCentral price target raised to $300 from $280 at Morgan Stanley
09/24/20 Lynx
Microsoft's Bethesda deal positive for AMD, says Lynx
DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

Hot Stocks
Auxly Cannabis reduces workforce to accelerate path to profitability » 07:57
10/01/20
10/01
07:57
10/01/20
07:57
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

07/16/20 Desjardins
Auxly Cannabis initiated with a Buy at Desjardins
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

Hot Stocks
Auxly Cannabis appoints Michael Lickver as president, Genevieve Young as chair » 07:55
10/01/20
10/01
07:55
10/01/20
07:55
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

Auxly Cannabis Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

07/16/20 Desjardins
Auxly Cannabis initiated with a Buy at Desjardins
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

Recommendations
Biogen panel meeting can be 'perception catalyst' for Lilly, says Morgan Stanley » 07:54
10/01/20
10/01
07:54
10/01/20
07:54
LLY

Eli Lilly

$148.09 /

+1.83 (+1.25%)

, BIIB

Biogen

$283.44 /

+1.11 (+0.39%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

09/30/20 H.C. Wainwright
Competitor data give Vir Biotechnology 'an opening,' says H.C. Wainwright
09/29/20 Berenberg
Eli Lilly initiated with a Hold at Berenberg
09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
BIIB Biogen
$283.44 /

+1.11 (+0.39%)

09/29/20 Morgan Stanley
Aducanumab AdComm could drive Biogen up or down 20%-30%, says Morgan Stanley
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/18/20 RBC Capital
Biogen price target lowered to $277 from $284 at RBC Capital
09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

Hot Stocks
Diginex lists, begins trading on Nasdaq » 07:53
10/01/20
10/01
07:53
10/01/20
07:53
EQOS

Diginex

$8.98 /

+0.175 (+1.99%)

, JFK

8i Enterprises Acquisition Corp.

$0.00 /

+ (+0.00%)

Diginex Limited (EQOS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JFK 8i Enterprises Acquisition Corp.
$0.00 /

+ (+0.00%)

JFK 8i Enterprises Acquisition Corp.
$0.00 /

+ (+0.00%)

Hot Stocks
Edison Nation acquires TBD Safety, terms not disclosed » 07:53
10/01/20
10/01
07:53
10/01/20
07:53
EDNT

Edison Nation

$1.80 /

+0.06 (+3.45%)

Edison Nation informs…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDNT Edison Nation
$1.80 /

+0.06 (+3.45%)

EDNT Edison Nation
$1.80 /

+0.06 (+3.45%)

Recommendations
2U price target lowered to $34 from $44 at DA Davidson » 07:52
10/01/20
10/01
07:52
10/01/20
07:52
TWOU

2U

$33.85 /

-1.33 (-3.78%)

DA Davidson analyst Rishi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWOU 2U
$33.85 /

-1.33 (-3.78%)

TWOU 2U
$33.85 /

-1.33 (-3.78%)

09/24/20 KeyBanc
Initial enrollment data from NSCRC 'positive' for Chegg, says KeyBanc
08/03/20 BMO Capital
2U price target raised to $54 from $48 at BMO Capital
07/31/20 Barrington
2U price target raised to $55 from $50 at Barrington
07/31/20 Credit Suisse
2U upgraded to Outperform from Neutral at Credit Suisse
TWOU 2U
$33.85 /

-1.33 (-3.78%)

  • 06
    Aug
TWOU 2U
$33.85 /

-1.33 (-3.78%)

TWOU 2U
$33.85 /

-1.33 (-3.78%)

Hot Stocks
AnPac Bio announces up to $7M equity investment from Keystone » 07:52
10/01/20
10/01
07:52
10/01/20
07:52
ANPC

AnPac Bio

$3.79 /

-0.24 (-5.96%)

AnPac Bio-Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANPC AnPac Bio
$3.79 /

-0.24 (-5.96%)

ANPC AnPac Bio
$3.79 /

-0.24 (-5.96%)

  • 30
    Jan
Hot Stocks
The Pennant Group, Scripps Health close joint venture » 07:50
10/01/20
10/01
07:50
10/01/20
07:50
PNTG

The Pennant Group

$38.55 /

+1.93 (+5.27%)

The Pennant Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNTG The Pennant Group
$38.55 /

+1.93 (+5.27%)

PNTG The Pennant Group
$38.55 /

+1.93 (+5.27%)

08/13/20 Truist
The Pennant Group price target raised to $40 from $25 at Truist
08/13/20 Stephens
The Pennant Group price target raised to $44 from $30 at Stephens
07/21/20
Fly Intel: Top five analyst initiations
07/20/20 Stephens
The Pennant Group initiated with an Overweight at Stephens
PNTG The Pennant Group
$38.55 /

+1.93 (+5.27%)

General news
Treasury Market Outlook: Q4 is kicking off in rally mode with equities firmer » 07:50
10/01/20
10/01
07:50
10/01/20
07:50

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
McDonald's price target raised to $244 from $222 at Wells Fargo » 07:49
10/01/20
10/01
07:49
10/01/20
07:49
MCD

McDonald's

$219.50 /

+0.75 (+0.34%)

Wells Fargo analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCD McDonald's
$219.50 /

+0.75 (+0.34%)

MCD McDonald's
$219.50 /

+0.75 (+0.34%)

09/17/20 Longbow
McDonald's Travis Scott Meal launch drove surge in comps, says Longbow
09/14/20 UBS
McDonald's price target raised to $230 from $215 at UBS
09/14/20 Piper Sandler
McDonald's price target raised to $203 from $197 at Piper Sandler
08/18/20 KeyBanc
McDonald's price target raised to $225 from $215 at KeyBanc
MCD McDonald's
$219.50 /

+0.75 (+0.34%)

MCD McDonald's
$219.50 /

+0.75 (+0.34%)

MCD McDonald's
$219.50 /

+0.75 (+0.34%)

MCD McDonald's
$219.50 /

+0.75 (+0.34%)

Hot Stocks
Revival Gold nominates Maura Lendon to board » 07:49
10/01/20
10/01
07:49
10/01/20
07:49
RVLGF

Revival Gold

$0.00 /

+ (+0.00%)

Revival Gold announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVLGF Revival Gold
$0.00 /

+ (+0.00%)

RVLGF Revival Gold
$0.00 /

+ (+0.00%)

08/28/20 PI Financial
Revival Gold price target lowered to C$1.35 from C$1.40 at PI Financial
Hot Stocks
Kaleido Biosciences appoints Daniel Menichella as president, CEO » 07:49
10/01/20
10/01
07:49
10/01/20
07:49
KLDO

Kaleido Biosciences

$11.12 /

+0.93 (+9.13%)

, CVAC

CureVac

$46.56 /

+1.01 (+2.22%)

Kaleido Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLDO Kaleido Biosciences
$11.12 /

+0.93 (+9.13%)

CVAC CureVac
$46.56 /

+1.01 (+2.22%)

KLDO Kaleido Biosciences
$11.12 /

+0.93 (+9.13%)

09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
05/21/20 Morgan Stanley
Morgan Stanley downgrades Kaleido to Equal Weight amid delays for key programs
05/21/20 Morgan Stanley
Kaleido downgraded to Equal Weight from Overweight at Morgan Stanley
CVAC CureVac
$46.56 /

+1.01 (+2.22%)

09/08/20 Jefferies
CureVac initiated with a Hold at Jefferies
09/08/20 BofA
CureVac initiated with a Buy at BofA
09/08/20 Credit Suisse
CureVac initiated with a Neutral at Credit Suisse
09/08/20 BofA
CureVac initiated with a Buy at BofA
KLDO Kaleido Biosciences
$11.12 /

+0.93 (+9.13%)

  • 14
    Aug
  • 02
    Jun
CVAC CureVac
$46.56 /

+1.01 (+2.22%)

KLDO Kaleido Biosciences
$11.12 /

+0.93 (+9.13%)

CVAC CureVac
$46.56 /

+1.01 (+2.22%)

CVAC CureVac
$46.56 /

+1.01 (+2.22%)

Recommendations
Burlington Stores price target raised to $240 from $225 at Loop Capital » 07:48
10/01/20
10/01
07:48
10/01/20
07:48
BURL

Burlington Stores

$206.12 /

+1.59 (+0.78%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$206.12 /

+1.59 (+0.78%)

BURL Burlington Stores
$206.12 /

+1.59 (+0.78%)

08/28/20 Loop Capital
Burlington Stores price target lowered to $225 from $250 at Loop Capital
08/28/20 RBC Capital
Burlington Stores price target raised to $235 from $225 at RBC Capital
08/24/20 RBC Capital
Burlington Stores price target lowered to $225 from $250 at RBC Capital
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
BURL Burlington Stores
$206.12 /

+1.59 (+0.78%)

BURL Burlington Stores
$206.12 /

+1.59 (+0.78%)

Hot Stocks
DraftKings signs deal to be official DFS and sports betting partner of Eagles » 07:48
10/01/20
10/01
07:48
10/01/20
07:48
DKNG

DraftKings

$58.85 /

+3.01 (+5.39%)

DraftKings and the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DKNG DraftKings
$58.85 /

+3.01 (+5.39%)

DKNG DraftKings
$58.85 /

+3.01 (+5.39%)

09/30/20 Needham
DraftKings initiated with a Buy at Needham
09/27/20 Jefferies
William Hill deal with Caesars makes strategic sense, says Jefferies
09/25/20
Fly Intel: Top five analyst initiations
09/25/20 Argus
DraftKings initiated with a Buy at Argus
DKNG DraftKings
$58.85 /

+3.01 (+5.39%)

  • 19
    Jun
DKNG DraftKings
$58.85 /

+3.01 (+5.39%)

DKNG DraftKings
$58.85 /

+3.01 (+5.39%)

DKNG DraftKings
$58.85 /

+3.01 (+5.39%)

Hot Stocks
Jacobs Engineering granted sustainability engineering contract by LA Metro » 07:47
10/01/20
10/01
07:47
10/01/20
07:47
J

Jacobs Engineering

$92.65 /

-0.155 (-0.17%)

Jacobs has been selected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
J Jacobs Engineering
$92.65 /

-0.155 (-0.17%)

J Jacobs Engineering
$92.65 /

-0.155 (-0.17%)

09/22/20 Bernstein
Jacobs initiated with an Outperform at Bernstein
07/01/20 Stifel
Jacobs secures 'key strategic, highly competitive' takeaway win, says Stifel
05/12/20 Argus
Jacobs price target lowered to $100 from $116 at Argus
05/11/20 DA Davidson
Jacobs price target lowered to $95 from $110 at DA Davidson
J Jacobs Engineering
$92.65 /

-0.155 (-0.17%)

J Jacobs Engineering
$92.65 /

-0.155 (-0.17%)

J Jacobs Engineering
$92.65 /

-0.155 (-0.17%)

Hot Stocks
Athira Pharma initiates patient dosing for LIFT-AD study » 07:47
10/01/20
10/01
07:47
10/01/20
07:47
ATHA

Athira Pharma

$18.70 /

+2.68 (+16.73%)

Athira Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 18
    Sep
ATHA Athira Pharma
$18.70 /

+2.68 (+16.73%)

Hot Stocks
Constellation Brands says Q2 comparable loss for Canopy Growth totaled $34.1M  07:46
10/01/20
10/01
07:46
10/01/20
07:46
STZ

Constellation Brands

$189.71 /

+2.155 (+1.15%)

, STZ.B

Constellation Brands; also tag STZ

$188.50 /

+ (+0.00%)

, CGC

Canopy Growth

$14.32 /

-0.175 (-1.21%)

 
ShowHide Related Items >><<
STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

CGC Canopy Growth
$14.32 /

-0.175 (-1.21%)

STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

09/29/20 RBC Capital
Constellation Brands valuation compelling heading into Q2, says RBC Capital
09/28/20 Morgan Stanley
Constellation's forward commentary likely to be key focus, says Morgan Stanley
09/04/20 MKM Partners
Constellation Brands struggles to replenish inventory, says MKM Partners
07/09/20
Fly Intel: Top five analyst upgrades
STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
04/13/20 Evercore ISI
Beer production not resuming in Mexico, says Evercore ISI
04/08/20 Guggenheim
Constellation Brands downgraded to Neutral on incremental risks at Guggenheim
CGC Canopy Growth
$14.32 /

-0.175 (-1.21%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
08/11/20 Canaccord
Canopy Growth price target raised to C$22 from C$21 at Canaccord
07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

CGC Canopy Growth
$14.32 /

-0.175 (-1.21%)

CGC Canopy Growth
$14.32 /

-0.175 (-1.21%)

STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

CGC Canopy Growth
$14.32 /

-0.175 (-1.21%)

STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

CGC Canopy Growth
$14.32 /

-0.175 (-1.21%)

Hot Stocks
Constellation Brands expects Gallo, Nobilo transactions to close by end of 3Q21 » 07:44
10/01/20
10/01
07:44
10/01/20
07:44
STZ

Constellation Brands

$189.71 /

+2.155 (+1.15%)

, STZ.B

Constellation Brands; also tag STZ

$188.50 /

+ (+0.00%)

Expects divestment of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

09/29/20 RBC Capital
Constellation Brands valuation compelling heading into Q2, says RBC Capital
09/28/20 Morgan Stanley
Constellation's forward commentary likely to be key focus, says Morgan Stanley
09/04/20 MKM Partners
Constellation Brands struggles to replenish inventory, says MKM Partners
07/09/20
Fly Intel: Top five analyst upgrades
STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/17/20 JPMorgan
Constellation Brands added to Analyst Focus List at JPMorgan
04/13/20 Evercore ISI
Beer production not resuming in Mexico, says Evercore ISI
04/08/20 Guggenheim
Constellation Brands downgraded to Neutral on incremental risks at Guggenheim
STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

STZ.B Constellation Brands; also tag STZ
$188.50 /

+ (+0.00%)

STZ Constellation Brands
$189.71 /

+2.155 (+1.15%)

Hot Stocks
Akerna and Dutchie integrate for optimization of cannabis e-commerce » 07:43
10/01/20
10/01
07:43
10/01/20
07:43
KERN

Akerna

$3.64 /

-0.09 (-2.41%)

Akerna announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KERN Akerna
$3.64 /

-0.09 (-2.41%)

KERN Akerna
$3.64 /

-0.09 (-2.41%)

09/24/20 Alliance Global Partners
Akerna post-earnings selloff overdone, says Alliance Global Partners
KERN Akerna
$3.64 /

-0.09 (-2.41%)

KERN Akerna
$3.64 /

-0.09 (-2.41%)

KERN Akerna
$3.64 /

-0.09 (-2.41%)

Hot Stocks
Cedar Fair provides business, liquidity update » 07:43
10/01/20
10/01
07:43
10/01/20
07:43
FUN

Cedar Fair

$28.12 /

+0.8 (+2.93%)

Attendance at the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FUN Cedar Fair
$28.12 /

+0.8 (+2.93%)

FUN Cedar Fair
$28.12 /

+0.8 (+2.93%)

07/09/20
Fly Intel: Top five analyst downgrades
07/09/20 Janney Montgomery Scott
Janney Montgomery Scott downgrades 'consensus long' Cedar Fair to Neutral
07/09/20 Janney Montgomery Scott
Janney Montgomery Scott upgrades Six Flags to Buy in theme park preference shift
07/09/20 Janney Montgomery Scott
Cedar Fair downgraded to Neutral from Buy at Janney Montgomery Scott
FUN Cedar Fair
$28.12 /

+0.8 (+2.93%)

FUN Cedar Fair
$28.12 /

+0.8 (+2.93%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.